New England Journal of Medicine· 2012Q1· Clinical trial

Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis

Anders Perner, Nicolai Haase, Anne Berit Guttormsen, Jyrki Tenhunen et al.

1,829citations
Q1SCImago
2012year

Short summary

In severe sepsis patients, fluid resuscitation with Hydroxyethyl Starch (HES) 130/0.42 led to a higher risk of death at 90 days (51% vs. 43%) and increased need for renal-replacement therapy compared to Ringer's acetate.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Critical Care and Intensive Care Medicine

Critical Care and Intensive Care MedicineMedicine